LZAGF - Lonza: Excellent Growth Projections Will Sharply Increase Free Cash Flow

2024-01-27 10:40:00 ET

Summary

• Lonza Group aims to increase revenue by double digits by 2028 through aggressive expansion in the CDMO space.
• Lonza expects to increase its EBITDA margin to 32%-34% by 2028 and maintain a low debt ratio.
• The company plans to generate 25% of its revenue as underlying free cash flow by 2028, supporting its growth ambitions.

Introduction

The Lonza Group ( LZAGF ) is a chemical and biotech company providing high quality ingredients to the pharmaceutical industry, where it has been building and maintaining long-term relationships with its customer base. It recently started an aggressive expansion program in the CDMO space, where it acts as a third party manufacturer of drugs or components for drugs. Lonza continues to invest in growth and has outlined an ambitious plan to increase its revenue by a double-digit number between now and 2028....

For further details see: